004310 — Hyundai Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Hyundai Pharmaceutical Co, fiscal year end - November 30th, KRW millions except per share, conversion factor applied.

	R2019 November 30th	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th
Period Length:	—	—	—	—	—
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,498	19,884	21,916	33,779	18,291
Net Total Accounts Receivable
Net Total Receivables	45,100	42,358	40,336	42,461	38,973
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71,644	80,503	84,896	101,643	85,473
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	30,592	29,567	29,261	28,601	29,436
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	147,240	157,502	163,857	181,159	154,629
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	49,418	51,779	45,850	80,696	65,334
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	63,062	67,361	77,257	94,604	69,968
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	84,178	90,141	86,600	86,555	84,661
Total Liabilities & Shareholders' Equity	147,240	157,502	163,857	181,159	154,629
Total Common Shares Outstanding